http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101798664-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-515 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
filingDate | 2009-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2017-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2017-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101798664-B1 |
titleOfInvention | Inhibition of plgf to treat philadelphia chromosome positive leukemia |
abstract | The present invention relates to the field of leukemias, particularly how PIGF inhibition can aid in treating Philadelphia chromosome positive (Ph +) leukemia. Methods of treating Ph + leukemias by administering PIGF inhibitors are provided. The use of PIGF inhibitors for the treatment of Ph + leukemia or for the manufacture of a medicament for Ph + leukemia is also disclosed. |
priorityDate | 2008-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 221.